Investments in the new Russian plant will reach 5.3 billion rubles

Print 05 June 2017
GMP News

The investments in Pharmoslavl, the plant for manufacturing the active pharmaceutical substances, which will be launched in the Yaroslavl region before the end of 2017, will amount to 5.3 billion rubles. This was announced at the St. Petersburg Economic Forum (SPIEF) by Dmitry Mironov, the acting Governor of Yaroslavl region.

“Pharmoslavl, the plant of active pharmaceutical substances, will be launched before the end of this year. The company is focused on the production of more than 50 import-substituting active pharmaceutical substances, which are the basis for innovative and highly effective medicinal products. The investments in the project are about 5.3 billion rubles, and there will be more than 200 new jobs,” said Mr. Mironov.

According to acting Governor, the project will allow to reduce dependence on imports, as the Russian pharmaceutical companies will be able to obtain high-quality medicinal products at a much lower price.

Source

Return